797 related articles for article (PubMed ID: 29766830)
21. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
[TBL] [Abstract][Full Text] [Related]
22. [Sphingosine kinase 1 and tumor].
Zhang CX; He HW; Shao RG
Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
[TBL] [Abstract][Full Text] [Related]
23. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
24. Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.
Frati A; Ricci B; Pierucci F; Nistri S; Bani D; Meacci E
Mol Endocrinol; 2015 Jan; 29(1):53-67. PubMed ID: 25415609
[TBL] [Abstract][Full Text] [Related]
25. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
[TBL] [Abstract][Full Text] [Related]
26. Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.
Tani M; Igarashi Y; Ito M
J Biol Chem; 2005 Nov; 280(44):36592-600. PubMed ID: 16126722
[TBL] [Abstract][Full Text] [Related]
27. Nerve growth factor, sphingomyelins, and sensitization in sensory neurons.
Nicol GD
Sheng Li Xue Bao; 2008 Oct; 60(5):603-4. PubMed ID: 18958367
[TBL] [Abstract][Full Text] [Related]
28. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
[TBL] [Abstract][Full Text] [Related]
29. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
[TBL] [Abstract][Full Text] [Related]
30. Ceramide/sphingomyelin cycle involvement in gentamicin-induced cochlear hair cell death.
Chi le NU; Tabuchi K; Nakamagoe M; Nakayama M; Nishimura B; Hara A
Arch Toxicol; 2015 Mar; 89(3):415-21. PubMed ID: 24798086
[TBL] [Abstract][Full Text] [Related]
31. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
Ueda N
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
[TBL] [Abstract][Full Text] [Related]
32. Translocation and activation of sphingosine kinase 1 by ceramide-1-phosphate.
Nishino S; Yamashita H; Tamori M; Mashimo M; Yamagata K; Nakamura H; Murayama T
J Cell Biochem; 2019 Apr; 120(4):5396-5408. PubMed ID: 30444039
[TBL] [Abstract][Full Text] [Related]
33. High levels of sphingolipids in human breast cancer.
Nagahashi M; Tsuchida J; Moro K; Hasegawa M; Tatsuda K; Woelfel IA; Takabe K; Wakai T
J Surg Res; 2016 Aug; 204(2):435-444. PubMed ID: 27565080
[TBL] [Abstract][Full Text] [Related]
34. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase.
Facchinetti MM; Beuret C; Marquez MG; Sterin-Speziale N
Biol Neonate; 2003; 84(3):243-51. PubMed ID: 14504448
[TBL] [Abstract][Full Text] [Related]
35. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
36. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
37. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
De Luca T; Morré DM; Morré DJ
J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipid metabolism in cancer signalling and therapy.
Ogretmen B
Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
[TBL] [Abstract][Full Text] [Related]
39. Sphingosine-1-phosphate and ceramide-1-phosphate promote migration, pro-inflammatory and pro-fibrotic responses in retinal pigment epithelium cells.
Simón MV; Vera MS; Tenconi PE; Soto T; Prado Spalm FH; Torlaschi C; Mateos MV; Rotstein NP
Exp Eye Res; 2022 Nov; 224():109222. PubMed ID: 36041511
[TBL] [Abstract][Full Text] [Related]
40. Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells.
Abdel Hadi L; Di Vito C; Marfia G; Ferraretto A; Tringali C; Viani P; Riboni L
PLoS One; 2015; 10(11):e0143384. PubMed ID: 26580959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]